U.S. market Closed. Opens in 16 hours 26 minutes

SRDX | Surmodics, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 37.39 - 37.77
52 Week Range 25.17 - 42.44
Beta 1.13
Implied Volatility 31.29%
IV Rank 30.99%
Day's Volume 105,927
Average Volume 298,967
Shares Outstanding 14,267,000
Market Cap 536,011,190
Sector Healthcare
Industry Medical - Devices
IPO Date 1998-03-04
Valuation
Profitability
Growth
Health
P/E Ratio -417.44
Forward P/E Ratio N/A
EPS -0.09
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 376
Country USA
Website SRDX
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
*Chart delayed
Analyzing fundamentals for SRDX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is strong. For more detailed analysis please see SRDX Fundamentals page.

Watching at SRDX technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on SRDX Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙